Showing results (1881-1890 of 2,037) with videos related to

Sort By:
Pageof 204
Nature Communications|September 24, 2020
Risk prediction of late-onset Alzheimer's disease implies an oligogenic architectureQian Zhang, Julia Sidorenko, Baptiste Couvy-Duchesne, et al.
Neurology|January 30, 2013
Criteria for the diagnosis of corticobasal degenerationMelissa J Armstrong, Irene Litvan, Anthony E Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate CancerSusan Halabi, Qian Yang, Akash Roy, et al.
Annals of the American Thoracic Society|September 14, 2020
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial HypertensionRobert A Lewis, Catherine G Billings, Judith A Hurdman, et al.
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|November 12, 2021
Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trialSusan Halabi, Qian Yang, Andrea Carmack, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217Breton M Asken, Rosie E Curiel Cid, Elizabeth A Crocco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2024
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancerD E Rathkopf, M R Patel, A D Choudhury, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2023
Plasma Alzheimer's biomarkers and brain amyloid in Hispanic and non-Hispanic older adultsBreton M Asken, Wei-En Wang, Karen McFarland, et al.
Pageof 204